178 related articles for article (PubMed ID: 33891492)
1. Clinical Audit of Survival Outcomes and Prognostic Factors in Adolescents and Adults with Medulloblastoma.
Patil R; Gupta T; Maitre M; Dasgupta A; Sahay A; Epari S; Shirsat N; Chatterjee A; Krishnatry R; Goda JS; Moiyadi A; Patil V; Chinnaswamy G; Bano N; Jalali R
J Adolesc Young Adult Oncol; 2022 Feb; 11(1):68-77. PubMed ID: 33891492
[No Abstract] [Full Text] [Related]
2. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
Khalil EM
J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of concurrent carboplatin during full-dose craniospinal irradiation for high-risk/metastatic medulloblastoma in a resource-limited setting.
Gupta T; Sinha S; Chinnaswamy G; Vora T; Prasad M; Bhat V; Goda JS; Krishnatry R; Chatterjee A; Epari S; Sahay A; Moiyadi A; Shetty P; Patil V; Khatua S; Jalali R; Kurkure P
Pediatr Blood Cancer; 2021 May; 68(5):e28925. PubMed ID: 33533557
[TBL] [Abstract][Full Text] [Related]
4. Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.
Rieken S; Gaiser T; Mohr A; Welzel T; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
BMC Cancer; 2010 Aug; 10():450. PubMed ID: 20731859
[TBL] [Abstract][Full Text] [Related]
5. Management and Long-term Outcomes of Adults With Medulloblastoma: A Single-Center Experience.
Neth BJ; Raghunathan A; Kizilbash SH; Uhm JH; Breen WG; Johnson DR; Daniels DJ; Sener U; Carabenciov ID; Campian JL; Khatua S; Mahajan A; Ruff MW
Neurology; 2023 Sep; 101(12):e1256-e1271. PubMed ID: 37524533
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma in adults : A retrospective single institution analysis.
Hadi I; Roengvoraphoj O; Niyazi M; Roeder F; Schüller U; Belka C; Nachbichler SB
Strahlenther Onkol; 2018 Mar; 194(3):225-234. PubMed ID: 29147840
[TBL] [Abstract][Full Text] [Related]
7. Adult medulloblastoma: multiagent chemotherapy.
Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
[TBL] [Abstract][Full Text] [Related]
8. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.
Herrlinger U; Steinbrecher A; Rieger J; Hau P; Kortmann RD; Meyermann R; Schabet M; Bamberg M; Dichgans J; Bogdahn U; Weller M
J Neurol; 2005 Mar; 252(3):291-9. PubMed ID: 16189725
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes and role of chemotherapy in adults with newly diagnosed medulloblastoma.
Call JA; Naik M; Rodriguez FJ; Giannini C; Wu W; Buckner JC; Parney IF; Laack NN
Am J Clin Oncol; 2014 Feb; 37(1):1-7. PubMed ID: 23111362
[TBL] [Abstract][Full Text] [Related]
10. Outcome and prognostic factors of radiation therapy for medulloblastoma.
Rieken S; Mohr A; Habermehl D; Welzel T; Lindel K; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e7-e13. PubMed ID: 21345611
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
Atalar B; Ozsahin M; Call J; Napieralska A; Kamer S; Villa S; Erpolat P; Negretti L; Lassen-Ramshad Y; Onal C; Akyurek S; Ugurluer G; Baumert BG; Servagi-Vernat S; Miller RC; Ozyar E; Sio TT
Radiother Oncol; 2018 Apr; 127(1):96-102. PubMed ID: 29373196
[TBL] [Abstract][Full Text] [Related]
12. Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.
Hill RM; Richardson S; Schwalbe EC; Hicks D; Lindsey JC; Crosier S; Rafiee G; Grabovska Y; Wharton SB; Jacques TS; Michalski A; Joshi A; Pizer B; Williamson D; Bailey S; Clifford SC
Lancet Child Adolesc Health; 2020 Dec; 4(12):865-874. PubMed ID: 33222802
[TBL] [Abstract][Full Text] [Related]
13. Survival and prognostic factors in a series of adults with medulloblastomas.
Riffaud L; Saikali S; Leray E; Hamlat A; Haegelen C; Vauleon E; Lesimple T
J Neurosurg; 2009 Sep; 111(3):478-87. PubMed ID: 19231932
[TBL] [Abstract][Full Text] [Related]
14. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
Kortmann RD; Kühl J; Timmermann B; Mittler U; Urban C; Budach V; Richter E; Willich N; Flentje M; Berthold F; Slavc I; Wolff J; Meisner C; Wiestler O; Sörensen N; Warmuth-Metz M; Bamberg M
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):269-79. PubMed ID: 10661332
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.
Gupta T; Maitre M; Sastri GJ; Krishnatry R; Shirsat N; Epari S; Sahay A; Chinnaswamy G; Patil V; Shetty P; Moiyadi A
J Neurooncol; 2019 Sep; 144(2):283-291. PubMed ID: 31236820
[TBL] [Abstract][Full Text] [Related]
16. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
[TBL] [Abstract][Full Text] [Related]
17. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
18. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ;
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563
[TBL] [Abstract][Full Text] [Related]
19. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.
Massimino M; Antonelli M; Gandola L; Miceli R; Pollo B; Biassoni V; Schiavello E; Buttarelli FR; Spreafico F; Collini P; Giangaspero F
Pediatr Blood Cancer; 2013 Feb; 60(2):210-6. PubMed ID: 22693015
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
